SG Americas Securities
TEVA icon

SG Americas Securities’s Teva Pharmaceuticals TEVA Stock Holding History

SG Americas Securities’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-299,800
Closed -$971K – 3692
2025
Q4 		$971K Buy
+299,800
New +$7.39M ﹤0.01% 2048
2020
Q2 		– Sell
-233,700
Closed -$37K – 3854
2020
Q1 		$37K Buy
233,700
+108,700
+87% +$1.11M ﹤0.01% 3223
2019
Q4 		$1K Hold
125,000
– – ﹤0.01% 3252
2019
Q3 		$1K Hold
125,000
– – ﹤0.01% 2966
2019
Q2 		$4K Hold
125,000
– – ﹤0.01% 3026
2019
Q1 		$56K Sell
125,000
-75,000
-38% -$1.32M ﹤0.01% 3172
2018
Q4 		$2K Buy
+200,000
New +$4.1M ﹤0.01% 3009
2018
Q1 		– Sell
-25,000
Closed -$98K – 3540
2017
Q4 		$98K Buy
+25,000
New +$376K ﹤0.01% 2865
2016
Q2 		– Sell
-103,400
Closed -$131K – 2965
2016
Q1 		$131K Sell
103,400
-47,400
-31% -$2.78M ﹤0.01% 2460
2015
Q4 		$1.61M Buy
+150,800
New +$9.32M 0.01% 845
2015
Q3 		– Sell
-211,200
Closed -$1.12M – 2665
2015
Q2 		$1.12M Sell
211,200
-132,800
-39% -$8.19M 0.01% 1028
2015
Q1 		$1.62M Buy
+344,000
New +$20M 0.01% 912
2014
Q1 		– Sell
-100,000
Closed -$244K – 2775
2013
Q4 		$244K Hold
100,000
– – ﹤0.01% 1957
2013
Q3 		$147K Hold
100,000
– – ﹤0.01% 2391
2013
Q2 		$279K Buy
+100,000
New +$3.89M ﹤0.01% 1554

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SG Americas Securities's TEVA Position: Q1 2026 in Review

SG Americas Securities increased its Teva Pharmaceuticals (TEVA) stake by 232% in Q1 2026, buying an estimated $17.6M and bringing the position to 780,518 shares worth $23.5M. The position accounts for 0.03% of the portfolio, ranked #485.

SG Americas Securities first reported a position in TEVA in Q2 2013 and has held it in 50 quarters since. The position peaked at $53.7M in Q2 2014. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • SG Americas Securities held 780,518 shares of Teva Pharmaceuticals worth $23.5M as of Q1 2026.
  • SG Americas Securities bought 545,601 Teva Pharmaceuticals shares in Q1 2026, an estimated $17.6M.
  • Teva Pharmaceuticals made up 0.03% of SG Americas Securities's portfolio in Q1 2026, its #485 holding.
  • SG Americas Securities first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 50 quarters since.
  • SG Americas Securities's Teva Pharmaceuticals position peaked at $53.7M in Q2 2014.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.